Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | +3.01% | +12.30% | -8.67% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 123M |
---|---|---|---|---|---|
Net income 2024 * | -93M | Net income 2025 * | -104M | EV / Sales 2024 * | - |
Net cash position 2024 * | 33.12M | Net Debt 2025 * | 55.55M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.39
x | P/E ratio 2025 * |
-1.38
x | Employees | 77 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.28% |
Latest transcript on Immunic, Inc.
1 day | +3.01% | ||
1 week | +12.30% | ||
Current month | +8.73% | ||
1 month | +12.30% | ||
3 months | +12.30% | ||
6 months | +21.24% | ||
Current year | -8.67% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Vitt
CEO | Chief Executive Officer | 55 | 16-12-31 |
Glenn Whaley
DFI | Director of Finance/CFO | 56 | 19-11-30 |
Hella Kohlhof
CTO | Chief Tech/Sci/R&D Officer | 51 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barclay Phillips
BRD | Director/Board Member | 61 | 19-11-18 |
Tamar Howson
BRD | Director/Board Member | 75 | 19-10-10 |
Jörg Neermann
BRD | Director/Board Member | 57 | 19-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.37 | +3.01% | 112,415 |
24-05-02 | 1.33 | +2.31% | 134,753 |
24-05-01 | 1.3 | +3.17% | 127,974 |
24-04-30 | 1.26 | +2.44% | 224,863 |
24-04-29 | 1.23 | +0.82% | 170,561 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.67% | 123M | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- IMUX Stock